Related Experiment Video

Updated: Sep 26, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

HIV vaccines in infants and children: past trials, present plans and future perspectives

Jeffrey T Safrit1

  • 1Elizabeth Glaser Pediatric AIDS Foundation, Department of Pediatrics, David Geffin School of Medicine, University of California, Los Angeles, USA. jeff@pedaids.org

Current Molecular Medicine
|April 18, 2003
PubMed

Insights

This review examines pediatric HIV vaccine trials, including successes, failures in macaque models, and future prospects for preventing mother-to-child transmission and establishing long-term immunity.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Review of past pediatric vaccine successes.
  • Examination of the neonatal macaque model for Simian Immunodeficiency Virus (SIV) infection.
  • Discussion of challenges and successes in pediatric HIV vaccine development.

Purpose of the Study:

  • To review the recent history of human immunodeficiency virus (HIV) vaccine trials in pediatric populations.
  • To discuss the implications of studies using the neonatal macaque model of SIV infection.
  • To outline current and planned pediatric HIV vaccine trials and future perspectives.

Main Methods:

  • Literature review of pediatric HIV vaccine trials.
  • Analysis of data from neonatal macaque models of SIV infection.
  • Synthesis of information on ongoing and planned clinical trials.

Main Results:

  • Overview of historical successes and failures in pediatric vaccine development.
  • Insights from SIV-infected macaque models regarding potential efficacy and safety.
  • Identification of a limited number of ongoing and planned pediatric HIV vaccine trials.

Conclusions:

  • Pediatric HIV vaccine research faces unique challenges but holds significant promise.
  • The neonatal macaque model provides valuable insights into vaccine efficacy and safety.
  • Future HIV vaccines aim to prevent mother-to-child transmission and establish lifelong immunity in children.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.